Novartis | NVS - Market Capitalization


Novartis reported $314.11B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bausch Health Companies USD 3.48B 873.55M Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.09T 37.2B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
J&J USD 611.36B 32.21B Jun/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pacira USD 1.28B 286M Aug/2026
Perrigo USD 1.45B 135M Aug/2026
Pfizer USD 143.89B 5.44B Aug/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sanofi EUR 113.52B 3.82B Mar/2026
Supernus Pharmaceuticals USD 2.52B 181M Aug/2026
Zoetis USD 49.71B 5.74B Mar/2026